| Code | 1067B | ||||||||||
| MA number | 44/0255/14-S | ||||||||||
| Product Form: | emp med 4x8 mg (vre.papier/LDPE/Al/etylén.kopolymér) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | sachet paper LDPE/Al/ ethylene copolymer | ||||||||||
| Route of admin.: | Cutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 18.08.2014 |
| SPC: |
SPC_Alacare 8 mg liečivá náplasť_07/2020.doc.docx
|
| PIL: |
PIL_Alacare 8 mg liečivá náplasť_08.2022.pdf
|
| Safety feature | Yes |
| Data update: | 21.07.2020 |
